爱德士实验室

最新新闻

• 评级变动
  Citi Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Raises Target Price to $670
  \u5e02\u573a\u8d44\u8baf · 2026/8/5
• 评级变动
  BofA Securities Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Maintains Target Price $660
  \u5e02\u573a\u8d44\u8baf · 2026/7/8
• 评级变动
  Stifel Maintains IDEXX Laboratories Inc(IDXX.US) With Buy Rating, Maintains Target Price $775
  \u5e02\u573a\u8d44\u8baf · 2026/2/28
• 评级变动
  UBS Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Cuts Target Price to $620
  \u5e02\u573a\u8d44\u8baf · 2026/7/27
• UBS Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Maintains Target Price $670
  \u5e02\u573a\u8d44\u8baf · 2026/9/16
• 评级变动
  Jefferies Maintains IDEXX Laboratories Inc(IDXX.US) With Buy Rating, Cuts Target Price to $729
  \u5e02\u573a\u8d44\u8baf · 2026/5/7
• 评级变动
  BofA Securities Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Maintains Target Price $790
  \u5e02\u573a\u8d44\u8baf · 2026/4/28
• 评级变动
  UBS Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Maintains Target Price $730
  \u5e02\u573a\u8d44\u8baf · 2026/3/24
• 评级变动
  Barclays Maintains IDEXX Laboratories Inc(IDXX.US) With Buy Rating, Cuts Target Price to $710
  \u5e02\u573a\u8d44\u8baf · 2026/8/11
• William Blair Maintains IDEXX Laboratories Inc(IDXX.US) With Buy Rating
  \u5e02\u573a\u8d44\u8baf · 2026/10/2
• Analysts Conflicted on These NA Names: Rapport Therapeutics, Inc. (RAPP), Idexx Laboratories (IDXX) and Waystar Holding Corp. (WAY)
  TipRanks · 2026/9/16
• Stifel Maintains IDEXX Laboratories Inc(IDXX.US) With Buy Rating, Maintains Target Price $675
  \u5e02\u573a\u8d44\u8baf · 2026/8/14
• 评级变动
  Citi Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Maintains Target Price $650
  \u5e02\u573a\u8d44\u8baf · 2026/4/16
• BofA Securities Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Raises Target Price to $665
  \u5e02\u573a\u8d44\u8baf · 2026/8/14
• 评级变动
  UBS Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Cuts Target Price to $640
  \u5e02\u573a\u8d44\u8baf · 2026/4/28
• 评级变动
  BofA Securities Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Cuts Target Price to $660
  \u5e02\u573a\u8d44\u8baf · 2026/5/6
• 评级变动
  UBS Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Raises Target Price to $670
  \u5e02\u573a\u8d44\u8baf · 2026/8/5
• 评级变动
  Stifel Maintains IDEXX Laboratories Inc(IDXX.US) With Buy Rating, Cuts Target Price to $675
  \u5e02\u573a\u8d44\u8baf · 2026/3/31
• 评级变动
  Citi Initiates IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Announces Target Price $650
  \u5e02\u573a\u8d44\u8baf · 2026/4/15
• 评级变动
  Morgan Stanley Maintains IDEXX Laboratories Inc(IDXX.US) With Buy Rating, Maintains Target Price $805
  \u5e02\u573a\u8d44\u8baf · 2026/8/5
• William Blair Maintains IDEXX Laboratories Inc(IDXX.US) With Buy Rating
  \u5e02\u573a\u8d44\u8baf · 2026/8/14

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。